SCHEMBL12907416

SCHEMBL12907416

Cc1n[nH]c2ccc(-c3ccccc3CO)cc12

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CHEK1 O14757 1/20 0.49
▸ PAK1 Q13153 1/20 0.45
▸ MAP2K4 P45985 3/20 0.45
▸ MAPK1 P28482 1/20 0.45
▸ MAPKAPK2 P49137 1/20 0.45
▸ MAPKAPK3 Q16644 1/20 0.45
▸ MAPK6 Q16659 1/20 0.45
▸ JAK2 O60674 3/20 0.45
▸ JAK1 P23458 1/20 0.45
▸ TYK2 P29597 1/20 0.45
▸ JAK3 P52333 1/20 0.45
▸ MKNK1 Q9BUB5 1/20 0.43
▸ TRPA1 O75762 1/20 0.43
▸ CYP1A2 P05177 1/20 0.42
▸ FGFR1 P11362 1/20 0.40
▸ FGFR2 P21802 1/20 0.40
▸ FGFR3 P22607 1/20 0.40
▸ WNT1 P04628 1/20 0.40
▸ DYRK1A Q13627 1/20 0.40
▸ MAP3K8 P41279 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12907178 0.84 JAK2 (0.63) CHEK1PAK1MAPK1MAPKAPK2JAK2
SCHEMBL12907440 0.81 JAK2 (0.48) PAK1MAP2K4MAPK1MAPKAPK2MAPKAPK3
SCHEMBL18271123 0.77 FGFR2 (0.76) MAPK1FGFR1FGFR2FGFR3
SCHEMBL27968550 0.76 MKNK1 (0.71) CHEK1MAP2K4JAK2MKNK1CYP1A2
SCHEMBL6855076 0.74 AKT1 (0.52) CHEK1PAK1MAPK1MAPKAPK2JAK2
SCHEMBL12907412 0.73 BRD4 (0.46) CHEK1PAK1JAK2JAK1TYK2
SCHEMBL15637885 0.72 JAK2 (0.48) PAK1MAP2K4JAK2JAK1TYK2
SCHEMBL12907439 0.71 MAPK1 (0.59) CHEK1MAP2K4MAPK1MAPKAPK2MAPKAPK3
SCHEMBL5476788 0.71 JAK2 (0.47) PAK1JAK2JAK1TYK2JAK3
SCHEMBL12907433 0.71 MKNK1 (0.51) CHEK1MAP2K4MAPK1MAPKAPK2MAPKAPK3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7872039-B2 N-3-chlorobenzyl-3-amino-1H-indazole-5-carboxamide; 3-aminoindazoles; glucocorticoid-depedent kinase (SGK) inhibitors; SGK-induced diseases; diabetes, obesity, metabolic syndrome (dyslipidaemia), systemic and pulmonary hypertonia, cardiovascular diseases and renal diseases, fibrosis; inflammatory agents MERCK PATENT GESELLSCHAFT (DE) 2011-01-18 — — US disclosed
Send feedback